AI and biomanufacturing

AI and biomanufacturing: India play a pivotal role to harness artificial intelligence (AI) for biotechnology innovation through initiatives like the BioE3 Policy and IndiaAI Mission. These reflect a bold vision to position the country as a global leader in AI-driven biomanufacturing and ethical AI development. 

• About Biomanufacturing: It refers to the use of cells or other living microorganisms to produce commercially viable products. Vaccines, monoclonal antibodies, and proteins for medicinal use are all produced using biomanufacturing.
• India’s First Biomanufacturing Institute, BRIC-National Agri-Food Bio-Manufacturing Institute (BRIC-NABI), inaugurated in Mohali.
• BioE3 Policy: It will explore biomanufacturing applications in agriculture, food, pharmaceuticals, and energy sectors, aligned with the eco-friendly goals.

o It will scale up efforts in high-performance biomanufacturing with a stated ambition of achieving a US $300 billion bioeconomy by 2030.

o Implementation: Department of Biotechnology (DBT).

o Salient Features:

- It includes innovation-driven support to R&D and entrepreneurship across thematic sectors.

- Through this Policy, the government will delineate an ambitious vision to achieve technology leadership and tackle major challenges with focused mission in six thematic sectors.